UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$495M |
| 2 |
Microsoft
MSFT
|
+$480M |
| 3 |
Global Payments
GPN
|
+$400M |
| 4 |
Mastercard
MA
|
+$274M |
| 5 |
Comcast
CMCSA
|
+$254M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSS
Total System Services, Inc.
TSS
|
+$225M |
| 2 |
WP
Worldpay, Inc.
WP
|
+$190M |
| 3 |
Apple
AAPL
|
+$167M |
| 4 |
RHT
Red Hat Inc
RHT
|
+$166M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.77% |
| 2 | Financials | 14.07% |
| 3 | Healthcare | 13.13% |
| 4 | Consumer Discretionary | 12.1% |
| 5 | Communication Services | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
TTM Technologies
TTMI
$14.5B
| $891K | ﹤0.01% |
73,076
+16,566
| +29% | +$178K |
|
1977
Newmark Group
NMRK
$2.63B
| $886K | ﹤0.01% |
97,804
+22,652
| +30% | +$210K |
|
1978
Veracyte
VCYT
$3.8B
| $884K | ﹤0.01% |
36,820
+9,002
| +32% | +$239K |
|
1979
Kornit Digital
KRNT
$791M
| $881K | ﹤0.01% |
28,617
+14,717
| +106% | +$439K |
|
1980
Usana Health Sciences
USNA
$286M
| $880K | ﹤0.01% |
12,866
+3,694
| +40% | +$248K |
|
1981
Matsons
MATX
$6.18B
| $878K | ﹤0.01% |
23,415
+1,898
| +9% | +$72.1K |
|
|
AIMT
1982
DELISTED
Aimmune Therapeutics
AIMT
| $877K | ﹤0.01% |
41,887
+843
| +2% | +$17.2K |
|
1983
Anika Therapeutics
ANIK
$287M
| $869K | ﹤0.01% |
15,833
+9,198
| +139% | +$472K |
|
|
TGA
1984
DELISTED
Transglobe Energy Corp
TGA
| $868K | ﹤0.01% |
652,294
-65,127
| -9% | -$92.5K |
|
1985
Clean Energy Fuels
CLNE
$346M
| $866K | ﹤0.01% |
419,155
+37,081
| +10% | +$86.2K |
|
1986
Genesco
GCO
$422M
| $858K | ﹤0.01% |
21,427
-2,366
| -10% | -$91.3K |
|
1987
Avantor
AVTR
$9.19B
| $851K | ﹤0.01% |
+57,903
| New | +$981K |
|
1988
Innoviva
INVA
$1.48B
| $848K | ﹤0.01% |
80,453
+21,414
| +36% | +$256K |
|
1989
Helios Technologies
HLIO
$2.76B
| $847K | ﹤0.01% |
20,887
-908
| -4% | -$39.5K |
|
1990
Unitil
UTL
$980M
| $845K | ﹤0.01% |
13,313
+832
| +7% | +$49.9K |
|
1991
AtriCure
ATRC
$2.11B
| $841K | ﹤0.01% |
33,735
+2,853
| +9% | +$81.5K |
|
1992
Arbor Realty Trust
ABR
$998M
| $838K | ﹤0.01% |
63,954
+3,458
| +6% | +$43.2K |
|
1993
Tronox
TROX
$1.04B
| $837K | ﹤0.01% |
100,789
+6,390
| +7% | +$61.6K |
|
1994
G-III Apparel Group
GIII
$1.5B
| $835K | ﹤0.01% |
32,392
-4,100
| -11% | -$103K |
|
1995
First Busey Corp
BUSE
$2.56B
| $834K | ﹤0.01% |
33,008
+8,193
| +33% | +$210K |
|
|
XIFR
1996
XPLR Infrastructure LP
XIFR
$1.08B
| $833K | ﹤0.01% |
15,758
+6,567
| +71% | +$330K |
|
1997
Scholastic
SCHL
$792M
| $831K | ﹤0.01% |
22,015
+3,171
| +17% | +$111K |
|
|
FOE
1998
DELISTED
Ferro Corporation
FOE
| $828K | ﹤0.01% |
69,826
+1,830
| +3% | +$23.2K |
|
1999
Koppers
KOP
$969M
| $827K | ﹤0.01% |
28,303
+9,684
| +52% | +$268K |
|
2000
Vanguard Morningstar Mega Cap Growth ETF
MGK
$34.2B
| $822K | ﹤0.01% |
30,995
-225
| -0.7% | -$5.95K |
|
Similar funds
UBS AM's Q3 2019 Portfolio in Review
As of Q3 2019, UBS AM held 2,935 positions worth $148B, up 5.8% from $140B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
UBS AM deployed $6.46B of net new capital in Q3 2019, opening 79 new positions and adding to 1,853 existing holdings. Its largest new stake was 10x Genomics: 184,683 shares worth $9.31M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $167M trimmed.
- UBS AM's largest Q3 2019 buy was 10x Genomics: 184,683 shares worth $9.31M.
- UBS AM added most to Alibaba in Q3 2019, an estimated $495M increase.
- UBS AM's biggest Q3 2019 reduction was Apple, cutting an estimated $167M.
- UBS AM fully exited Total System Services, Inc. in Q3 2019, selling an estimated $225M.
- UBS AM's ten largest holdings make up 19% of its $148B portfolio in Q3 2019.
- UBS AM opened 79 new positions and closed 50 in Q3 2019.
- UBS AM's portfolio value rose 5.8% quarter-over-quarter to $148B.
Based on UBS AM's 13F filing for Q3 2019, filed 14 Nov 2019.